Know Cancer

or
forgot password

An International Field-Testing Study Of The Reliability And Validity Of A Patient Satisfaction Module (QLQ-SAT32) Assessing Cancer Patients' Perception Of The Quality Of Care Received Within The Hospital


N/A
18 Years
N/A
Not Enrolling
Both
Unspecified Adult Solid Tumor, Protocol Specific

Thank you

Trial Information

An International Field-Testing Study Of The Reliability And Validity Of A Patient Satisfaction Module (QLQ-SAT32) Assessing Cancer Patients' Perception Of The Quality Of Care Received Within The Hospital


OBJECTIVES:

- Determine the scale structure, reliability, and validity of the QLQ-SAT32 patient
satisfaction module in assessing the perception of the quality of care received in
hospitals by patients with cancer.

- Determine the success of the QLQ-SAT32 patient satisfaction module when used with the
QLQ-C30 core quality of life questionnaire, in terms of expanding on quality of life
evaluation or providing information on treatment acceptability or preference of these
patients.

OUTLINE: This is a descriptive, multicenter study. Patients are stratified according to age
(18 to 49 vs 50 and over) and the cancer therapy received in hospital (surgery vs
chemotherapy).

Patients in all strata receive the QLQ-SAT32 and QLQ-C30 questionnaires, a debriefing
questionnaire, and the Oberst patient satisfaction visual analog scale prior to hospital
discharge. Patients complete the materials at home within 7 days of discharge. A group of
100 patients have a repeat QLQ-SAT32 module mailed to them to be completed within 7 days of
receipt of first questionnaire.

PROJECTED ACCRUAL: A total of 640-768 patients (160-192 per stratum) will be accrued for
this study.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Histologically confirmed cancer

- Hospitalization of at least 3 days

- No clinical evidence of brain metastases

PATIENT CHARACTERISTICS:

Age

- 18 and over

Performance status

- Not specified

Life expectancy

- Not specified

Hematopoietic

- Not specified

Hepatic

- Not specified

Renal

- Not specified

Other

- No psychological, familial, sociological, or geographical condition that would
preclude study

- Able to understand the language of the questionnaire

- Mentally fit to complete a questionnaire

PRIOR CONCURRENT THERAPY:

Biologic therapy

- Not specified

Chemotherapy

- Prior chemotherapy allowed

Endocrine therapy

- Not specified

Radiotherapy

- Not specified

Surgery

- Prior surgery for cancer allowed

Other

- No concurrent participation in other quality of life studies that would preclude this
study

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Principal Investigator

Anne Bredart

Investigator Role:

Study Chair

Investigator Affiliation:

Institut Curie

Authority:

United States: Federal Government

Study ID:

EORTC-15012

NCT ID:

NCT00045019

Start Date:

May 2002

Completion Date:

March 2005

Related Keywords:

  • Unspecified Adult Solid Tumor, Protocol Specific
  • unspecified adult solid tumor, protocol specific

Name

Location